We are pleased to announce the start of a collaboration that will providethe Immun4Cure Institute with a multimodal digital platform to integrate, structure, and exploit its clinical and omics data.
This collaboration is essential to enable IHU teams to leverage their wealth of data and accelerate the development of innovative immunotherapies, their primary objective.
The goal of the collaboration: to provide an ADLIN environment capable of managing a wide range of data (clinical, biochemical, cytometry, imaging, omics) and to provide teams with: